The Efficacy Gap: Oral vs Injectable Injectable tirzepatide (Zepbound), a dual GLP-1 and GIP receptor agonist, produced weight reductions of between 16% and 22.5% over 72 weeks in the SURMOUNT trials
In 2025, the GLP-1 receptor agonist market was valued at $66.4 billion and is projected to grow to $82 billion in 2026
Theyre also low in fat, high in fiber, and contain various vitamins and minerals, such as folate, magnesium, and iron
SkinnyRx is a telehealth platform not itself a healthcare provider
Propranolol, a nonselective adrenergic receptor antagonist, has been shown to have a suppressive effect on hyperglycemia, inflammation and brain damage in a rat model of cerebral ischemia
The irony is that the weight loss theyre chasing for shape or aesthetics can be undermined by losing the very muscle that defines that shape without structured support